Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs Molecular Partners AG Sponsored ADR (MOLN)

Cue Biopharma, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. Cue Biopharma, Inc. is the larger, with a market value of $136.1M against $119.2M — 1.1× the size. Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against −28.0%. Molecular Partners AG Sponsored ADR has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Cue Biopharma, Inc. leads on 8 and Molecular Partners AG Sponsored ADR on 8.

Valuation

Metric CUE MOLN Biotechnology median
P/E n/m n/m 10.60
P/S 3.15 21.86 9.40
P/B 51.41 1.98 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.74 9.32 9.02
Earnings yield (143.53%) (52.05%) (32.88%)
Free cash flow yield (42.21%) (45.19%) (23.13%)

Profitability

Metric CUE MOLN Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (262.03%) 0.00% 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) (71.08%) (51.96%)
Return on assets (459.60%) (58.83%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUE MOLN Biotechnology median
Revenue growth (TTM) 354.37% (27.99%) 6.76%
EPS growth (last fiscal year) 61.11% (9.94%) 29.88%
Revenue growth, 5-year CAGR 54.16% (23.12%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE MOLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 6.46 4.97
Net debt to EBITDA 1.10 1.66 1.01

Dividend

Metric CUE MOLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CUE MOLN Biotechnology median
Market cap 136.06m 119.24m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack